Company Analysis Laboratory Corporation of America Holdings
1. Summary
Advantages
- The stock's return over the last year (9.8%) is higher than the sector average (-19.29%).
- Current debt level 31.25% is below 100% and has decreased over 5 years from 39.29%.
- The company's current efficiency (ROE=5.31%) is higher than the sector average (ROE=-82.41%)
Disadvantages
- Price (234.45 $) is higher than fair price (49.27 $)
- Dividends (1.27%) are below the sector average (1.27%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
Laboratory Corporation of America Holdings | Healthcare | Index | |
---|---|---|---|
7 days | -2.2% | -14.3% | -1.2% |
90 days | 2.2% | -14.8% | -6.6% |
1 year | 9.8% | -19.3% | 6.9% |
LH vs Sector: Laboratory Corporation of America Holdings has outperformed the "Healthcare" sector by 29.1% over the past year.
LH vs Market: Laboratory Corporation of America Holdings has outperformed the market by 2.89% over the past year.
Stable price: LH is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: LH with weekly volatility of 0.1885% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (234.45 $) is higher than the fair price (49.27 $).
Price is higher than fair: The current price (234.45 $) is 79% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (46.95) is lower than that of the sector as a whole (114.26).
P/E vs Market: The company's P/E (46.95) is lower than that of the market as a whole (73.03).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.49) is lower than that of the sector as a whole (9.02).
P/BV vs Market: The company's P/BV (2.49) is lower than that of the market as a whole (22.33).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.61) is lower than that of the sector as a whole (4.1).
P/S vs Market: The company's P/S indicator (1.61) is lower than that of the market as a whole (16).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (14.69) is lower than that of the sector as a whole (17.72).
EV/Ebitda vs Market: The company's EV/Ebitda (14.69) is lower than that of the market as a whole (23.03).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -14.64% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-14.64%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-50.52%).
5.4. ROE
ROE vs Sector: The company's ROE (5.31%) is higher than that of the sector as a whole (-82.41%).
ROE vs Market: The company's ROE (5.31%) is lower than that of the market as a whole (25.16%).
5.5. ROA
ROA vs Sector: The company's ROA (2.5%) is lower than that of the sector as a whole (6.75%).
ROA vs Market: The company's ROA (2.5%) is lower than that of the market as a whole (6.67%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (13.52%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (13.52%) is higher than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 1.27% is below the average for the sector '1.27%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 1.27% has been steadily paid over the past 7 years, DSI=0.71.
Weak dividend growth: The company's dividend yield 1.27% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (60.77%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription